Avience Biomedicals Limited

19/07/2026

🧪 Complete Pathology Setup Solution 🏥

From sample collection to accurate diagnosis, we provide a complete end-to-end pathology laboratory setup solution tailored to your requirements.

🔬 Complete Pathology Solutions Under One Roof
✅ Hematology
✅ Biochemistry
✅ Immunoassay & Chemiluminescence
✅ Clinical Chemistry
✅ Coagulation
✅ Urinalysis
✅ Fully Automated Laboratory Solutions
✅ Installation, Training & After-Sales Support

With 25+ Years of Experience in the Medical Field, we are committed to delivering advanced technology, reliable equipment, professional support, and better healthcare outcomes.

💙 Build your complete pathology laboratory with a trusted medical technology partner.

📩 Contact us today for a customized Complete Pathology Setup Solution.

16/07/2026

🚀 Upgrade Your Hematology Lab with the Mindray BC-6200

🔬 High Performance. Accurate Results. Trusted Technology.

Experience the power of the Mindray BC-6200 5-Part Differential Hematology Analyzer, designed to deliver reliable CBC testing with advanced clinical capabilities.

✅ Up to 110 Tests/Hour
✅ 5-Part WBC Differential with Immature Granulocyte (IG) detection
✅ NRBC Result in Every CBC
✅ Advanced SF Cube Technology for enhanced cell differentiation
✅ Low Sample Volume Requirement
✅ Intelligent Auto Rerun & Reflex Function
✅ Fast, Accurate & Reliable Performance

Ideal for:
🏥 Hospitals
🧪 Diagnostic Laboratories
🔬 Medical Colleges
❤️ Blood Banks

💼 Flexible Purchase Options Available
✔ Outright Purchase
✔ Reagent Rental Model
✔ Comprehensive Installation & Training
✔ PAN India Service Support

📞 Contact us today for a live demonstration and the best commercial offer.

Avience Biomedicals Ltd.
📧 [email protected]
🌐 Your Trusted Partner in Diagnostic Solutions

Experience spanning more than 20 years in the fields of molecular biotechnology and IVD business.

25/06/2026

🚀 BIG NEWS! AVIENCE BIOMEDICALS MAKES A BLOCKBUSTER STOCK MARKET DEBUT! 🚀

We are delighted to share that Avience Biomedicals Limited has achieved a remarkable milestone with its successful NSE SME listing on 25 June 2026.

📈 Listed at ₹395.20 against an IPO price of ₹208 – a phenomenal 90% premium!
📊 The stock further touched ₹414.95, reflecting strong investor confidence and market enthusiasm. The IPO also witnessed an overwhelming subscription of over 355 times.

This achievement reflects the trust placed in Avience's vision of delivering innovative and affordable diagnostic solutions across India and global markets.

🙏 Heartfelt thanks to our investors, customers, channel partners, employees, and well-wishers for being part of this incredible journey.

From Diagnostics to Growth, From Innovation to Value Creation — The Journey Has Just Begun!



🎉 Congratulations to the entire Avience family on this historic achievement! 🎉

25/06/2026